Specimen Transport Patents: Leaders, Trends & White Space 2026
Specimen Transport and Stability Patents: Who Leads and Where Filing Has Slowed
65.8% concentration. The top 5 of 27 ranked assignees account for 77 of the 117 records in scope — a field with a clear head and a long single-filer tail. Annual filings hit 16 in 2017, the high point of the dataset, then fell through the following years to 11 in 2021 and just 1 by 2024 — a 91% drop across that three-year window. Because publication lags filing, 2025 and 2026 figures will rise as later filings publish; they should not yet be read as confirmation of further decline.
- 1QURASENSE INC19
- 2VENTANA MEDICAL SYSTEMS INC18
- 3BECTON DICKINSON & CO18
- 4DORN GORDON L12
- 5BODE TECHNOLOGY GROUP INC10
See the full specimen transport and stability analysis in Eureka
- The complete ranking, not just the top five
- Every IPC branch with its share of the corpus
- The most-cited records, and where claim space is still thin
Common questions on specimen transport and stability patents
Who holds the most patents in specimen transport and stability?
Across the 117 records in this dataset, the leading assignee holds 19, and the top 5 of 27 ranked assignees together hold 77 records, or 65.8% of the field. That leaves a long tail: the tenth-ranked assignee holds only 4 records, and most of the remaining ranked companies appear with just a handful of filings each. This pattern — one clear leader, a mid-tier of a few sustained filers, and many single-filing entrants — is typical of a preanalytical niche rather than a broad, evenly contested technology area.
Is patent filing in specimen transport and stability growing or slowing?
Filing activity peaked in 2017 at 16 records and has fallen since, dropping from 11 in 2021 to 1 in 2024, a 91% decline over that span. 2024 is the most recent year with largely complete data, since patent publication typically lags filing by about 18 months, so 2025 and 2026 numbers will rise as pending filings publish. Based on the complete years, the field has cooled from its 2017 high rather than accelerated.
What technology areas dominate specimen transport patent claims?
Material analysis and testing (IPC class G01N) appears in 54.7% of the 117 records, making it the dominant classification by a wide margin. Implants/prostheses (A61F, 23.1%), lab apparatus (B01L, 21.4%) and diagnosis/surgery (A61B, 19.7%) follow at meaningfully lower shares. Containers & packaging (B65D) and bioreactor apparatus (C12M) each sit at just 9.4%, marking them as the least-claimed of the eight tracked classes and a possible entry point for narrower claims.
Disclaimer. This analysis is based on Patsnap Eureka data drawn from a limited snapshot of global patent records and is provided for general information and reference only. Patent data carries inherent limitations — recent filings are under-counted because of publication lag, counts may be on a record or family basis, classification and applicant-name data may contain errors or duplicates, and the underlying search query defines the scope shown — so the analysis may be incomplete or inaccurate and may not reflect the full technology landscape.
Nothing here is an exhaustive prior-art, novelty, freedom-to-operate or validity search, nor does it constitute legal, financial or professional advice, and it should not be relied upon as such. Verify independently and review with qualified patent and legal professionals before acting on it.
Method: Filing trend and technology composition. Derived from a Patsnap search on Specimen Transport and Stability covering 2015–2026, data cut-off 2026-07-31. Counts reflect published records only and shift as new filings publish. Every share divides by all records in scope. Data: Patsnap Eureka. See the full landscape report.